Stay updated on Nivolumab and Trabectedin in Soft Tissue Sarcomas Clinical Trial

Sign up to get notified when there's something new on the Nivolumab and Trabectedin in Soft Tissue Sarcomas Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab and Trabectedin in Soft Tissue Sarcomas Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The update appears to be cosmetic updates to the page layout and formatting. There are no changes to the study's purpose, eligibility criteria, primary/secondary outcomes, or scheduling details.
    Difference
    0.4%
    Check dated 2025-11-03T13:45:52.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    37 days ago
    Change Detected
    Summary
    Added a government funding lapse notice and a v3.2.0 version tag, replacing the prior v3.1.0.
    Difference
    3%
    Check dated 2025-10-06T04:24:07.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    Version tag updated from v3.0.2 to v3.1.0; no substantive content changes detected.
    Difference
    0.1%
    Check dated 2025-09-28T23:40:26.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.0.2, replacing v3.0.1, signaling a minor patch to the core content. The 'Back to Top' link was removed as a minor UI adjustment.
    Difference
    0.2%
    Check dated 2025-09-14T09:56:44.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.
    Difference
    0.2%
    Check dated 2025-09-07T07:59:31.000Z thumbnail image
  8. Check
    74 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location, as well as various scientific terms related to proteins and antibodies. Notably, the previous mentions of certain antineoplastic agents and the specific term 'Soft Tissue Sarcoma' have been removed.
    Difference
    2%
    Check dated 2025-08-31T01:08:12.000Z thumbnail image

Stay in the know with updates to Nivolumab and Trabectedin in Soft Tissue Sarcomas Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab and Trabectedin in Soft Tissue Sarcomas Clinical Trial page.